Pancreatic Cancer Research

Clinical trialNACompleted

Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas

Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas.

NCT00918853↗ ClinicalTrials.gov, retrieved 6 November 2026

Outcome
Finished, no results posted
Phase
NA
Status
Completed
Study type
Interventional
Start
August 2008
Expected end
May 2012
Enrollment
156 participants
Sites
20
Primary outcomes
Prognostic value of the invasion of the margins measured in millimetres on the overall survival
Sponsor
Other
Results posted
No
Last update
20 March 2015

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This multicentric prospective study evaluates the role of the margins resection and the ganglionic status when using a quality standard for the resection of adenocarcinoma of the head of the pancreas.

Detailed description public domain (ClinicalTrials.gov)

Primary objective: * Evaluation of the prognosis role of the invasion of the margins on the overall survival after a standard resection of adenocarcinoma of the head of the pancreas. Secondary objectives: * Evaluation of the prognosis role of the invasion: * Of margins on the overall survival. * Of each margins (distal pancreatic margin, gastric, posterior, retro-venous, retro-arterial) on the overall survival. * Of the ganglionic group of the superior mesenteric artery and the other nodes.

Papers 2